The similar effects between S1P induction and S1PR1 reduction indicate that other S1PRs such as S1PR2, which has demonstrated effects against S1PR1 (28, 94), should also be considered as therapeutic target for RA in the future. The gene discussed is S1PR1; the disease is rheumatoid arthritis.